Nammi Therapeutics

Nammi Therapeutics is an immuno-oncology company developing platforms and products that selectively activate anti-tumor immunity within the tumor microenvironment while minimizing systemic activation. They are focused on improving safety and combining multiple immune modulators through their Masked Immunocytokine (MIC) and nanoparticle platforms. This approach aims to enhance the efficacy of cancer treatments.

Buy Funded Startups lists

Funding Round: Series B

Funding Amount: $30M

Date: 06-Aug-2024

Investors: Myeloma Investment Fund (MIF)

Markets: Immuno-oncology, Biotechnology, Drug Discovery, Life Sciences, Oncology

HQ: Los Angeles, California, United States

Founded: 2018

Website: https://www.nammirx.com/

LinkedIn: https://www.linkedin.com/company/nammi-therapeutics-inc

Twitter:

Instagram: